excision repair cross-complementation 1 Search Results


90
Response Genetics Inc excision repair cross-complementation 1
Overall survival in relation to gene expression. a ratio of folypolyglutamyl synthase to gamma-glutamyl hydrolase (FPGS/GGH), High, ≥0.21 ( n = 14); Low, <0.21 ( n = 7), b vascular <t>endothelial</t> growth factor <t>(VEGF),</t> High, >2.19 ( n = 12); Low, ≤2.19 ( n = 10), c excision repair cross-complementation group 1 (ERCC1), High, ≥2.52 ( n = 15); Low, <2.52 ( n = 7)
Excision Repair Cross Complementation 1, supplied by Response Genetics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/excision repair cross-complementation 1/product/Response Genetics Inc
Average 90 stars, based on 1 article reviews
excision repair cross-complementation 1 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Response Genetics Inc excision repair cross-complementation 1 (ercc1)
Comparison of relative gene expression of thymidine <t>phosphorylase</t> in cancer specimens. PPC, pulmonary pleomorphic carcinoma; AC, adenocarcinoma; SCC, squamous cell carcinoma
Excision Repair Cross Complementation 1 (Ercc1), supplied by Response Genetics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/excision repair cross-complementation 1 (ercc1)/product/Response Genetics Inc
Average 90 stars, based on 1 article reviews
excision repair cross-complementation 1 (ercc1) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Overall survival in relation to gene expression. a ratio of folypolyglutamyl synthase to gamma-glutamyl hydrolase (FPGS/GGH), High, ≥0.21 ( n = 14); Low, <0.21 ( n = 7), b vascular endothelial growth factor (VEGF), High, >2.19 ( n = 12); Low, ≤2.19 ( n = 10), c excision repair cross-complementation group 1 (ERCC1), High, ≥2.52 ( n = 15); Low, <2.52 ( n = 7)

Journal: Journal of Cardiothoracic Surgery

Article Title: Tumor-related gene expression levels in thymic carcinoma and Type B3 thymoma

doi: 10.1186/s13019-016-0468-1

Figure Lengend Snippet: Overall survival in relation to gene expression. a ratio of folypolyglutamyl synthase to gamma-glutamyl hydrolase (FPGS/GGH), High, ≥0.21 ( n = 14); Low, <0.21 ( n = 7), b vascular endothelial growth factor (VEGF), High, >2.19 ( n = 12); Low, ≤2.19 ( n = 10), c excision repair cross-complementation group 1 (ERCC1), High, ≥2.52 ( n = 15); Low, <2.52 ( n = 7)

Article Snippet: Real time polymerase chain reaction (RT-PCR) assays were performed according to Danenberg’s tumor profile (DTP) method [ ] for semi-quantitation of mRNA of tumor-related genes (Response Genetics Inc., New York, USA), including thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD), thymidine phosphorylase (TP), dihydrofolate reductase (DHFR), gamma-glutamyl hydrolase (GGH), folypolyglutamyl synthase (FPGS), vascular endothelial growth factor (VEGF), excision repair cross-complementation group 1 (ERCC1), topoisomerase-1 (TOPO1), and epidermal growth factor receptor (EGFR).

Techniques: Gene Expression

Comparison of relative gene expression of thymidine phosphorylase in cancer specimens. PPC, pulmonary pleomorphic carcinoma; AC, adenocarcinoma; SCC, squamous cell carcinoma

Journal: Journal of Cardiothoracic Surgery

Article Title: Tumor-related gene expression levels in pulmonary pleomorphic carcinoma

doi: 10.1186/s13019-015-0282-1

Figure Lengend Snippet: Comparison of relative gene expression of thymidine phosphorylase in cancer specimens. PPC, pulmonary pleomorphic carcinoma; AC, adenocarcinoma; SCC, squamous cell carcinoma

Article Snippet: RT-PCR was performed according to Danenberg’s tumor profile (DTP) method [ ] for semi-quantitation of mRNA of tumor-related genes (Response Genetics Inc., New York, USA), including thymidylate synthase (TS), dihydropyrimidine dehydrogenase (DPD), thymidine phosphorylase (TP), excision repair cross-complementation group 1 (ERCC1), vascular endothelial growth factor (VEGF), and topoisomerase-1 (TOPO1).

Techniques: Comparison, Gene Expression